In 2023, Jim Chopas earned $575.00K in total compensation at Apellis Pharmaceuticals, Inc., including $350.00K salary, $50.00K bonus and $150.00K in stock. Most recently sold 1,096 shares in Jan 2025. Currently holds stock worth $1.26M. 4+ years at the helm of Apellis Pharmaceuticals, Inc..
Compensation History
Annual executive compensation data for Jim Chopas, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$575.00K
Salary
$350.00K
Bonus
$50.00K
Other
$25.00K
Salary
$350.00KBoard Justification
The compensation philosophy is designed to align the CEO's interests with those of shareholders, focusing on performance-based incentives and retention strategies.
Bonus
$50.00KBoard Justification
The bonus is based on the company's performance metrics and individual contributions during the fiscal year 2023, paid in cash.
Other Compensation
$25.00KBoard Justification
Other compensation includes health benefits, retirement contributions, and other perquisites provided to the CEO.
Restricted Stock
Board Justification
The vested stock consists of restricted stock units that were granted in prior years and vested in 2023, reflecting the company's stock performance and retention strategy.
Performance Metrics
Performance metrics include revenue growth, product launch success, and overall company financial health.
Jim Chopas
CEO of Apellis Pharmaceuticals, Inc.
Education
B.A. from University of Massachusetts; M.S. from Bentley University
Field of Expertise
Finance & Banking - Finance
Sector of Economy
Healthcare
CEO of Apellis Pharmaceuticals, Inc. for
4 years 3 months (Aug 2021 - Present)
Previous Experience
Vice President, Principal Financial Officer, Principal Accounting Officer and Treasurer of Radius Health, Inc.
Other Apellis Pharmaceuticals, Inc. CEOs
Holdings
Track Jim Chopas's stock holdings and portfolio value over time.
Total Stock Sold
$271.82K
$271.82K
6,128 APLS shares
What if they kept their stock?
If Jim Chopas didn't sell their stock, today they would have:
Extra APLS6,128 shares worth $144.80K.
This is -46.73% and $127.02K less than what they got when they sold the stock.
Insider Trading
Jim Chopas's recent stock transactions, purchases, and sales filed with the SEC.
$33.35K
APLS at $30.43/share
Jan 22, 2025
Sale
12,591 shares
APLS
Jan 17, 2025
Received
$21.42K
APLS at $29.96/share
Jan 17, 2025
Sale
$22.47K
APLS at $28.70/share
Jan 13, 2025
Sale
$6.95K
APLS at $36.21/share
Sep 16, 2024
Sale
$21.72K
APLS at $39.49/share
Sep 3, 2024
Sale
$10.39K
APLS at $56.46/share
Mar 15, 2024
Sale
$68.96K
APLS at $65.00/share
Jan 22, 2024
Sale
8,312 shares
APLS
Jan 16, 2024
Received
$57.72K
APLS at $66.81/share
Jan 16, 2024
Sale
Rivals
Compare Jim Chopas with competitor CEOs and industry peers.